<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:49Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5084729" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5084729</identifier><datestamp>2016-11-09</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="letter">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
      <journal-id journal-id-type="iso-abbrev">FEBS Lett</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1873-3468</journal-id>
      <journal-id journal-id-type="publisher-id">FEB2</journal-id>
      <journal-title-group>
        <journal-title>Febs Letters</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0014-5793</issn>
      <issn pub-type="epub">1873-3468</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5084729</article-id>
      <article-id pub-id-type="pmcid">PMC5084729</article-id>
      <article-id pub-id-type="pmc-uid">5084729</article-id>
      <article-id pub-id-type="pmid">27098453</article-id>
      <article-id pub-id-type="doi">10.1002/1873-3468.12180</article-id>
      <article-id pub-id-type="publisher-id">FEB212180</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Research Letter</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Research Letters</subject>
          <subj-group subj-group-type="heading">
            <subject>Signal transduction (Editor's choice)</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>
<styled-content style="fixed-case">WDR</styled-content>26 is a new partner of Axin1 in the canonical Wnt signaling pathway</article-title>
        <alt-title alt-title-type="left-running-head">T. Goto <italic>et al</italic>.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="feb212180-cr-0001" contrib-type="author">
          <name>
            <surname>Goto</surname>
            <given-names>Toshiyasu</given-names>
          </name>
          <xref ref-type="aff" rid="feb212180-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="feb212180-cr-0002" contrib-type="author">
          <name>
            <surname>Matsuzawa</surname>
            <given-names>Junhei</given-names>
          </name>
          <xref ref-type="aff" rid="feb212180-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="feb212180-cr-0003" contrib-type="author">
          <name>
            <surname>Iemura</surname>
            <given-names>Shunâichiro</given-names>
          </name>
          <xref ref-type="aff" rid="feb212180-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="feb212180-cr-0004" contrib-type="author">
          <name>
            <surname>Natsume</surname>
            <given-names>Tohru</given-names>
          </name>
          <xref ref-type="aff" rid="feb212180-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="feb212180-cr-0005" contrib-type="author" corresp="yes">
          <name>
            <surname>Shibuya</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref ref-type="aff" rid="feb212180-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="feb212180-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Department of Molecular Cell Biology</named-content>
        <named-content content-type="organisation-division">Medical Research Institute</named-content>
        <institution>Tokyo Medical and Dental University</institution>
        <country country="JP">Japan</country>
      </aff>
      <aff id="feb212180-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Molecular Profiling Research Center for Drug Discovery</named-content>
        <institution>National Institutes of Advanced Industrial Science and Technology</institution>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
H. Shibuya, Department of Molecular Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, 1â5â45 Yushima, Bunkyoâku, Tokyo 113â8510, Japan<break/>
Fax: +81 3 5803 4901<break/>
Tel: +81 3 5803 4901<break/>
Eâmail: <email>shibuya.mcb@mri.tmd.ac.jp</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <volume>590</volume>
      <issue>9</issue>
      <issue-id pub-id-type="doi">10.1111/feb2.2016.590.issue-9</issue-id>
      <fpage>1291</fpage>
      <lpage>1303</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 Federation of European Biochemical Societies <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. FEBS Letters published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</copyright-statement>
        <license license-type="creativeCommonsBy-nc-nd">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons AttributionâNonCommercialâNoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is nonâcommercial and no modifications or adaptations are made.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:FEB2-590-1291.pdf"/>
      <abstract id="feb212180-abs-0001">
        <p>The stability of Î²âcatenin is very important for canonical Wnt signaling. A protein complex including Axin/<styled-content style="fixed-case">APC</styled-content>/<styled-content style="fixed-case">GSK</styled-content>3Î² phosphorylates Î²âcatenin to be degraded by ubiquitination with Î²âTr<styled-content style="fixed-case">CP</styled-content>. In the recent study, we isolated <styled-content style="fixed-case">WDR</styled-content>26, a protein that binds to Axin. Here, we found that <styled-content style="fixed-case">WDR</styled-content>26 is a negative regulator of the canonical Wnt signaling pathway, and that <styled-content style="fixed-case">WDR</styled-content>26 affected Î²âcatenin levels. In addition, <styled-content style="fixed-case">WDR</styled-content>26/Axin binding is involved in the ubiquitination of Î²âcatenin. These results suggest that <styled-content style="fixed-case">WDR</styled-content>26 plays a negative role in Î²âcatenin degradation in the Wnt signaling pathway.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="feb212180-kwd-0001">Axin1</kwd>
        <kwd id="feb212180-kwd-0002">ubiquitination</kwd>
        <kwd id="feb212180-kwd-0003"><styled-content style="fixed-case">WDR</styled-content>26</kwd>
        <kwd id="feb212180-kwd-0004">Wnt</kwd>
        <kwd id="feb212180-kwd-0005">Î²âcatenin</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Ministry of Education, Culture, Sports, Science and Technology of Japan</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="13"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>feb212180</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>May 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.6 mode:remove_FC converted:28.10.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <fn-group id="feb212180-ntgp-0001">
        <fn id="feb212180-note-0001">
          <p>Edited by Lukas Alfons Huber</p>
        </fn>
        <fn id="feb212180-note-1101">
          <p>*The copyright line for this article was changed on 11 May 2016 after original online publication.</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <sec id="feb212180-sec-0001">
      <title>Abbreviations</title>
      <p>
<bold>CTLH</bold>, Câterminal to LisH</p>
      <p>
<bold>GID</bold> glucoseâinduced degradationâdeficient</p>
      <p>
<bold>LisH</bold>, lis homology</p>
      <p>
<bold>MO</bold>, morpholino oligonucleotides</p>
    </sec>
    <sec id="feb212180-sec-0002">
      <p>Wnt signaling plays multiple important roles in disease and embryogenesis <xref rid="feb212180-bib-0001" ref-type="ref">1</xref>, <xref rid="feb212180-bib-0002" ref-type="ref">2</xref>. Î²âCatenin is a key component in the canonical Wnt signaling pathway, and its stability and localization influence Wnt activity. Cytoplasmic levels of Î²âcatenin are kept low, in the âWnt offâ state, by a degradation complex that includes Axin, APC, and GSKâ3Î². CK1Î± initially phosphorylates Î²âcatenin at serine 45 (S45) of the Nâterminal region, and GSKâ3Î² subsequently phosphorylates Î²âcatenin at threonine 41 (T41), serine 37 (S37), and serine 33 (S33) <xref rid="feb212180-bib-0003" ref-type="ref">3</xref>. The phosphorylated Î²âcatenin is recognized and ubiquitinated at lysine 19 (K19) and lysine 49 (K49) by the ubiquitin E3 ligase, Î²âTrCP. The ubiquitinated Î²âcatenin is degraded by the proteasome <xref rid="feb212180-bib-0004" ref-type="ref">4</xref>. In the âWnt onâ state, the Wnt ligand binds to Frizzled receptor and the LRP complex at the cell surface, which leads to the membrane recruitment and activation of scaffold protein, Dishevelled. Activated Dishevelled inactivates the APC/Axin/GSKâ3 complex in the cytoplasm, thus reducing degradation of Î²âcatenin. The stabilized Î²âcatenin translocates to the nucleus and associates with TCF/LEF transcription factors to activate Wnt target genes <xref rid="feb212180-bib-0005" ref-type="ref">5</xref>.</p>
      <p>Axin1 is a scaffold protein including a multidomain that has many functions in biological signaling pathways. Axin1 contains: a regulation of Gâprotein signaling (RGS) domain, which binds to APC, at the Nâterminus; a dishevelled and axin (DIX) domain and a protein phosphatase 2 (PP2A)âbinding domain at the Câterminus; and binding domains of GSKâ3Î² and Î²âcatenin in the center region <xref rid="feb212180-bib-0006" ref-type="ref">6</xref>, <xref rid="feb212180-bib-0007" ref-type="ref">7</xref>. In the canonical Wnt pathway, Axin1 is a component of the Î²âcatenin destruction complex that negatively controls Wnt signaling. Axin1 downâregulates the amount of cytoplasmic Î²âcatenin, to function as a tumor suppressor gene, and several mutations of Axin1 have been identified in tumor cell lines <xref rid="feb212180-bib-0008" ref-type="ref">8</xref>, <xref rid="feb212180-bib-0009" ref-type="ref">9</xref>. In <italic>Xenopus</italic> development, Axin1 functions as a ventralizing gene <xref rid="feb212180-bib-0010" ref-type="ref">10</xref>. However, in zebrafish development, Axin1 shows dorsalizing activity in the JNKâmediated signal pathway <xref rid="feb212180-bib-0011" ref-type="ref">11</xref>. Thus, Axin1 is a multifunctional gene and its function is dependent on binding partners.</p>
      <p>WDR26 contains several proteinâinteracting domains: the lis homology domain (LisH); the Câterminal to LisH motif (CTLH) domain; and a WD40 repeat domain <xref rid="feb212180-bib-0012" ref-type="ref">12</xref>. A previous study suggested that WDR26 contributes to the MAPK signaling pathway <xref rid="feb212180-bib-0013" ref-type="ref">13</xref>. In a study of chemoattractive migration of leukocytes, WDR26 binds to the GÎ²âgamma complex and positively controls leukocyte migration <xref rid="feb212180-bib-0014" ref-type="ref">14</xref>, <xref rid="feb212180-bib-0015" ref-type="ref">15</xref>. However, there are no reports that WDR26 is associated with the Wnt signaling pathway. In the yeast <italic>Saccharomyces cerevisiae</italic>, nine glucoseâinduced degradationâdeficient (GID) genes (<italic>GID1âGID9</italic>) were isolated <xref rid="feb212180-bib-0016" ref-type="ref">16</xref>, <xref rid="feb212180-bib-0017" ref-type="ref">17</xref>. The GID complex, which comprises GID1âGID9 except for GID6, acts as a polyubiquitination enzyme in yeast. Eight vertebrate homologs that share high similarities of domain architecture to yeast GID complex genes have been identified <xref rid="feb212180-bib-0012" ref-type="ref">12</xref>. The following are the yeast GID complex genesand their corresponding vertebrate homologs: <italic>GID1/RanBP9</italic>;<italic> GID2/Rmnd5</italic>;<italic> GID3/UBE2H</italic>;<italic> GID4/C17ors39</italic>;<italic> GID5/ARMc8</italic>;<italic> GID7/WDR26</italic>;<italic> GID8/TWA1</italic>; and <italic>GID9/MAEA</italic>
<xref rid="feb212180-bib-0012" ref-type="ref">12</xref>. Recent studies showed that RMND5 and ARMc8 promote ubiquitination in vertebrates <xref rid="feb212180-bib-0018" ref-type="ref">18</xref>, <xref rid="feb212180-bib-0019" ref-type="ref">19</xref>, but it is still unknown whether other vertebrate homologs including WDR26 are associated with the ubiquitination pathway.</p>
      <p>Previously, WDR26 is identified as an Axin1âbinding protein <xref rid="feb212180-bib-0020" ref-type="ref">20</xref>. In the present study, we found that WDR26, with Axin1, controlled Î²âcatenin levels to negatively regulate the expression of Wnt target genes. We also found that the binding between Axin1 and WDR26 is necessary for the ubiquitination of Î²âcatenin. These results reveal a function of WDR26 in the canonical Wnt signaling pathway.</p>
    </sec>
    <sec id="feb212180-sec-0003">
      <title>Materials and methods</title>
      <sec id="feb212180-sec-0004">
        <title>Plasmid construction</title>
        <p>The human and <italic>Xenopus</italic> WDR26 and Axin1 were amplified by RTâPCR from cDNA templates prepared from HEK 293T cells and <italic>Xenopus</italic> embryos, respectively, and were subcloned into the pRK5 and modified pCS2+ vectors. Each truncated mutant was constructed by PCR and contained the following amino acid (aa) sequences. xWDR26â1: 1â283 aa, xWDR26â2: 1â434 aa, xWDR26â3: 97â611 aa, xWDR26â4: 284â611 aa, xWDR26â5: 435â611 aa, xWDR26âÎLisH: 1â63 aa and 97â611 aa, xWDR26âÎCTLH: 1â96 aa and 182â611 aa, xWDR26âÎLisHâCTLH: 1â63 aa and 182â611 aa, xAxin1â1: 1â230 aa, xAxin1â2: 1â450 aa, xAxin1â3: 1â610 aa, xAxin1â4: 231â841 aa, xAxin1â5: 451â841 aa, xAxin1â6: 611â841 aa. FLAG tags were fused to the Nâterminus of hWDR26 and xÎ²âcatenin, and Câterminus of Î²âglobin, xWDR26, and its truncated constructs. MYC tags were fused to the Nâterminus of hÎ²âcatenin and xÎ²âcatenin, and Câterminus of hAxin1. HA tag was fused to Nâterminus of ubiquitin.</p>
      </sec>
      <sec id="feb212180-sec-0005">
        <title>Embryo handling and morpholino oligonucleotides</title>
        <p>Capped mRNA were synthesized from linearized vectors using SP6 (Roche, Basel, Switzerland) and T7 (Toyobo, Osaka, Japan) RNA polymerase. The morpholino oligonucleotides (MO) (Gene Tools, LLC, Philomath, OR, USA) used here were previously reported <xref rid="feb212180-bib-0021" ref-type="ref">21</xref>, <xref rid="feb212180-bib-0022" ref-type="ref">22</xref> and are as follows: 5â²âCGCTGCCCCGTTAGCCTGCATGTTAâ3â² (<italic>xWDR26</italic>âMO). The specificity of each MO was confirmed by its ability to inhibit the translation of FLAGâtagged mRNA containing the targeted site with or without fiveâmismatched sequences. MO (10 ng) and FLAGâtagged mRNA (100 pg) were coinjected with Î²âglobinâFLAG mRNA (100 pg) as a loading control into the animal poles of fourâcell stage embryos, and the injected animal caps were dissected at stage 10. Lysates from the animal caps were subjected to western blotting with an antiâFLAG antibody (M2, Sigma, St. Louis, MO, USA).</p>
        <p>Morpholino oligonucleotides, mRNA, and plasmids were injected into two animal dorsal blastomeres at the eightâcell stage for observation of embryo phenotypes and RTâPCR analysis, into four animal blastomeres for western blot analysis, or into two ventral blastomeres at the fourâcell stage for RTâPCR analysis. The cytoplasmic and nuclear fractions were prepared as described with modifications <xref rid="feb212180-bib-0023" ref-type="ref">23</xref>. Quantitative RTâPCR analysis: Total RNA was prepared using TRIzol (Invitrogen, Carlsbad, CA, USA) from the injected region at the gastrula or neurula stage. cDNA synthesis was carried out using Moloney murine leukemia virus reverse transcriptase (Invitrogen). The sequences of the primer pairs were previously reported <xref rid="feb212180-bib-0024" ref-type="ref">24</xref>, <xref rid="feb212180-bib-0025" ref-type="ref">25</xref>, <xref rid="feb212180-bib-0026" ref-type="ref">26</xref> and as follows: <italic>xWDR26</italic>: Forward 5â²âATGGCAACCTGCTTGACTCCâ3â²; Reverse 5â²âACAGTACCGTCGTCAGAAGCâ3â². <italic>hWDR26</italic>: Forward 5â²âCCGGAACTCGCCTGCTTGTCâ3â²; Reverse 5â²âTGACATCCTCATCTGACTGGâ3â². <italic>Xnr3</italic>: Forward 5â²âCTTCTGCACTAGATTCTGâ3â²; Reverse 5â²âCAGCTTCTGGCCAAGACTâ3â². <italic>Xtwn</italic>: Forward 5â²âAACCCAAGAAGGCGACACTATCâ3â²; Reverse 5â²âGTGCCGATGGTAGGAAATGATCâ3â². <italic>Xenopus</italic> embryonic ornithine decarboxylase <italic>(xODC)</italic> was used for normalization of cDNA samples.</p>
      </sec>
      <sec id="feb212180-sec-0006">
        <title>Wholeâmount <italic>in situ</italic> hybridization</title>
        <p>Wholeâmount <italic>in situ</italic> hybridization was performed as previously described <xref rid="feb212180-bib-0027" ref-type="ref">27</xref>. A cDNA fragment of <italic>xWDR26</italic> (nucleotides 709â1836; GenBank Accession No. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="LC066599">LC066599</ext-link>) was subcloned into pBluescriot vectors, and used as templates to generate the digoxigeninâlabeled antisense and sense RNA probes.</p>
      </sec>
      <sec id="feb212180-sec-0007">
        <title>Antibodies, siRNA, and cell lines</title>
        <p>The antibodies used here were previously reported <xref rid="feb212180-bib-0022" ref-type="ref">22</xref>, <xref rid="feb212180-bib-0024" ref-type="ref">24</xref> and as follows: Peroxidase conjugated antiâGAPDH (G9295; Wako, Osaka, Japan), horseradish peroxidaseâconjugated antiârat IgG (GE, Little Chalfont, UK), antiâT7 (PM022, MBL, Nagoya, Japan), antiâHA (3F10, Roche), antiâWDR26 (NBP1â78041, Acris Antibodies, Herford, Germany), antiâÎ²âcatenin (ab32572, Abcam, Cambridge, UK) and antiâAxin1 (C76H11, Cell Signaling, Danvers, MA, USA). The target sequences of siRNA against human <italic>WDR26</italic> were 5â²âTACCAAATTCCGAAATCATGTCAâ3â² (<italic>siâhWDR26â1</italic>), 5â²âGGCCGATTAGCTTTGTTAAATGTâ3â² (<italic>siâhWDR26â2</italic>), and 5â²âATCCTATTATGTCTTTTACTATTâ3â² (<italic>siâhWDR26â3</italic>). Fourâday Wntâ3A conditioned medium from LâWntâ3A cells was used for Wnt stimulation of cultured cells. We used the following cell lines: HEK 293T cells, L cells, and L Wnt3A cells. The growth medium for each cell type is described in the American Type Culture Collection <xref rid="feb212180-bib-0022" ref-type="ref">22</xref>. Threeâday Wntâ3Aâconditioned medium from LâWntâ3A cells was used for Wnt stimulation of cultured cells. For western blotting analysis, at least three independent experiments were performed, and representative data were shown in figures.</p>
      </sec>
    </sec>
    <sec id="feb212180-sec-0008">
      <title>Results</title>
      <sec id="feb212180-sec-0009">
        <title>Interaction between WDR26 and Axin1</title>
        <p>To identify novel proteins that bind to human Axin1 (hAxin1), we previously performed a highâthroughput analysis of proteins that coimmunoprecipitated with hAxin1 in HEK 293 cells using direct nanoflow liquid chromatographyâcoupled tandem mass spectrometry <xref rid="feb212180-bib-0020" ref-type="ref">20</xref>. We identified human WDR26 (hWDR26) as a candidate protein that binds to hAxin1. The interaction of ectopically expressed hWDR26 with hAxin1 was confirmed in HEK 293T cells (Fig. <xref rid="feb212180-fig-0001" ref-type="fig">1</xref>A). The endogenous interaction of hWDR26 and hAxin1 was also confirmed in HEK 293T cells (Fig. <xref rid="feb212180-fig-0001" ref-type="fig">1</xref>B). Amino acid sequences of both WDR26 and Axin1 are well conserved between vertebrate homologs, and an interaction between ectopically expressed <italic>Xenopus</italic> WDR26 (xWDR26) with <italic>Xenopus</italic> Axin1 (xAxin1) was also confirmed in HEK 293T cells (Fig. <xref rid="feb212180-fig-0001" ref-type="fig">1</xref>C). To determine the region in xWDR26 responsible for binding to xAxin1, several truncated mutants of xWDR26 were examined using coimmunoprecipitation assays. We found that the Nâterminal region including LisH domain was responsible for binding to xAxin1 (Fig. <xref rid="feb212180-fig-0001" ref-type="fig">1</xref>D). Conversely, xWDR26 bound to xAxin1 at the central region including GSK3Î²âbinding domain (Fig. <xref rid="feb212180-fig-0001" ref-type="fig">1</xref>E).</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Interaction between <styled-content style="fixed-case">WDR</styled-content>26 and Axin1. (A) Interaction between ectopically expressed h<styled-content style="fixed-case">WDR</styled-content>26 and hAxin1 in <styled-content style="fixed-case">HEK</styled-content> 293T cells. Relative intensity of each western blot was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of hAxin1 were calculated. Their statistical significances were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &lt; 0.01 (between lane 3/lane 1 and lane 4/lane 2). (B) Interaction between endogenous h<styled-content style="fixed-case">WDR</styled-content>26 and hAxin1 in <styled-content style="fixed-case">HEK</styled-content> 293T cells. Cells were treated with 10 Î¼<sc>m</sc>
<styled-content style="fixed-case">MG</styled-content>â132 for 24 h to improve the detection. The endogenous interaction between h<styled-content style="fixed-case">WDR</styled-content>26 and hAxin1was not detected with an antiâ<styled-content style="fixed-case">WDR</styled-content>26 antibody (data not shown). (C) Interaction between ectopically expressed x<styled-content style="fixed-case">WDR</styled-content>26 and xAxin1 in <styled-content style="fixed-case">HEK</styled-content> 293T cells. Relative intensity of each western blot was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of x<styled-content style="fixed-case">WDR</styled-content>26 were calculated. Their statistical significances were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &lt; 0.001 (between lane 3/lane 1 and lane 4/lane 2). (D) Interactions among ectopically expressed xAxin1 and truncated x<styled-content style="fixed-case">WDR</styled-content>26 constructs. <styled-content style="fixed-case">WDR</styled-content>26 proteinâinteracting domains are labeled as follows: L: LisH (lis homology domain); C: <styled-content style="fixed-case">CTLH</styled-content> (Câterminal to LisH motif) domain; W: <styled-content style="fixed-case">WD</styled-content>40 repeat domain. Asterisks indicate higher molecular weight bands. Constructs were transfected into <styled-content style="fixed-case">HEK</styled-content> 293T cells. Relative intensity of each western blot was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of x<styled-content style="fixed-case">WDR</styled-content>26 constructs were calculated. Their statistical significances were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &gt; 0.5 (between lane 7/lane 2 and lane 8/lane 3). <italic>P</italic> &gt; 0.1 (between lane 7/lane 2 and lane 9/lane 4). <italic>P</italic> &lt; 0.001 (between lane 7/lane 2 and lane 10/lane 5). (E) Interactions among ectopically expressed x<styled-content style="fixed-case">WDR</styled-content>26 and truncated xAxin1 constructs. Axin1 proteinâinteracting domains are labeled as follows: R: <styled-content style="fixed-case">RGS</styled-content> (regulation of Gâprotein signaling) domain; G: <styled-content style="fixed-case">GSK</styled-content>3âÎ² binding domain; Î²: Î²âcatenin binding domain; D: <styled-content style="fixed-case">DIX</styled-content> (Dishevelled and axin) domain. Constructs were transfected into <styled-content style="fixed-case">HEK</styled-content> 293T cells. Relative intensity of each western blot was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of xAxin1 were calculated. Their statistical significances were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &lt; 0.01 (between lane 10/lane 2 and lane 11/lane 3). <italic>P</italic> &gt; 0.5 (between lane 10/lane 2 and lane 12/lane 4). <italic>P</italic> &gt; 0.05 (between lane 10/lane 2 and lane 13/lane 5). <italic>P</italic> &gt; 0.1 (between lane 10/lane 2 and lane 14/lane 6). <italic>P</italic> &lt; 0.01 (between lane 10/lane 2 and lane 15/lane 7). <italic>P</italic> &lt; 0.01 (between lane 10/lane 2 and lane 16/lane 8).</p>
          </caption>
          <graphic id="nlm-graphic-3" xlink:href="FEB2-590-1291-g001"/>
        </fig>
      </sec>
      <sec id="feb212180-sec-0010">
        <title>Expression patterns of <italic>xWDR26</italic> during Xenopus embryogenesis</title>
        <p>To assess the possible function of xWDR26 in <italic>Xenopus</italic> embryonic development, we first examined the temporal and spatial expression patterns of <italic>xWDR26</italic> by RTâPCR analysis and wholeâmount <italic>in situ</italic> hybridization (Fig. <xref rid="feb212180-fig-0002" ref-type="fig">2</xref>A,BâI). We found that the expression of <italic>xWDR26</italic> remained at a relatively constant level until stage 15, and tended to decrease slightly after stage 18 (Fig. <xref rid="feb212180-fig-0002" ref-type="fig">2</xref>A). Wholeâmount <italic>in situ</italic> hybridization revealed that <italic>xWDR26</italic> was expressed broadly until the gastrula stage (data not shown). Expression of <italic>xWDR26</italic> was gradually localized to the neural region from the late gastrula (Fig. <xref rid="feb212180-fig-0002" ref-type="fig">2</xref>B) to the early neurula stage (Fig. <xref rid="feb212180-fig-0002" ref-type="fig">2</xref>C). In the late neurula and tadpole stages, <italic>xWDR26</italic> was strongly expressed in the anterior neural region (Fig. <xref rid="feb212180-fig-0002" ref-type="fig">2</xref>D,E). These results suggest that xWDR26 might be involved in anterior formation in <italic>Xenopus</italic> embryos.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Expression of x<styled-content style="fixed-case">WDR</styled-content>26 during <italic>Xenopus</italic> embryogenesis. (A) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> revealed temporal expression of <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>. Numbers under lanes indicate developmental stages; U, unfertilized eggs. The value obtained for <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> was normalized to the level of <italic>x<styled-content style="fixed-case">ODC</styled-content> (ornithine decarboxylase)</italic>. The value of unfertilized eggs was set to 100 and other values were computed. Error bars represent standard deviation of the mean in three experiments. Statistical significances of <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>/<italic>x<styled-content style="fixed-case">ODC</styled-content></italic> between unfertilized eggs and other stages were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &gt; 0.05 (until stage 15, and stage 26), <italic>P</italic> &lt; 0.01 (after stage 18, except for stage 26). (BâI) Wholeâmount <italic>in situ</italic> hybridization. (BâE) Antiâsense <styled-content style="fixed-case">RNA</styled-content> probe of <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> c<styled-content style="fixed-case">DNA</styled-content> fragment was used. (FâI) Sense <styled-content style="fixed-case">RNA</styled-content> probe of <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> c<styled-content style="fixed-case">DNA</styled-content> fragment was used. (B and C). Expression of <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> gradually localizes to anterior neural region (B, stage 12; C, stage 15). (D and F) <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> is strongly expressed in the anterior neural region (D, stage 25; E, stage 30).</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="FEB2-590-1291-g002"/>
        </fig>
      </sec>
      <sec id="feb212180-sec-0011">
        <title>WDR26 is involved in the canonical Wnt pathway</title>
        <p>To determine whether WDR26 is involved in the canonical Wnt pathway, we investigated the effects of knockdown of WDR26 on canonical Wnt activity. We first validated antisense morpholino oligonucleotides for <italic>xWDR26</italic> (<italic>xWDR26</italic>âMO) in <italic>Xenopus</italic> embryonic cells and siRNA for <italic>hWDR26</italic> in cultured cells (Fig. <xref rid="feb212180-fig-0003" ref-type="fig">3</xref>). Although <italic>xWDR26</italic>âMO inhibited the translation of FLAGâtagged mRNA containing the targeted site, the translation of FLAGâtagged mRNA containing fiveâmismatched sequences at the targeted site was not inhibited by <italic>xWDR26</italic>âMO (Fig. <xref rid="feb212180-fig-0003" ref-type="fig">3</xref>A). This result suggest <italic>xWDR26</italic>âMO could be targeted to knockdown specifically xWDR26. The transfection of each <italic>siâhWDR26</italic> RNA reduced <italic>hWDR26</italic> mRNA expression (Fig. <xref rid="feb212180-fig-0003" ref-type="fig">3</xref>B). Since the knockdown by <italic>siâWDR26â3</italic> RNA was slightly effective rather than other siRNA, we used <italic>siâWDR26â3</italic> RNA for the following experiments. A reduction in Wnt activity in the anterior region is necessary for head formation in <italic>Xenopus</italic> development <xref rid="feb212180-bib-0028" ref-type="ref">28</xref>, <xref rid="feb212180-bib-0029" ref-type="ref">29</xref>. The injection of <italic>xWDR26</italic>âMO into dorsoâanimal blastomeres of eightâcell embryos reduced both head formation at the tadpole stage (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>A) and the expression of several neural marker genes at the neural stage (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>B, lane 1 and lane 2). The injection of xWDR26 plasmids containing the MOâtargeted site with fiveâmismatched sequences slightly increased the expression of several neural marker genes, except for xRXâ1 (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>B, lane 1 and lane 3). These reductions of head formation and neural marker gene expression by the knockdown of xWDR26 were partially rescued by coinjection of xWDR26 plasmids (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>A, B, lane 2 and lane 4). When <italic>Xwntâ8</italic> mRNA is injected into the ventral sides of fourâcell embryos, the target genes of Wnt signaling are induced (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>C, lane 2 and lane3). Ventral injection of <italic>xWDR26</italic>âMO tended to increase the expression of Wnt target genes that were induced by coinjection of <italic>Xwntâ8</italic> mRNA (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>C, lane 3 and lane 4). Coinjection of <italic>xWDR26</italic> mRNA containing the MOâtargeted site with fiveâmismatched sequences tended to be restituted with the increasing of Wnt target genes by <italic>xWDR26</italic>âMO (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>C, lane 5 and lane 6). The coinjection of <italic>hWDR26</italic> mRNA showed similar results to the coinjection of <italic>xWDR26</italic> (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>D). The knockdown of <italic>hWDR26</italic> by siRNA in cultured cells did not affect the expression of a Wnt target gene, Axin2, in the âWnt offâ state (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>E, lane 1 and lane 2). This suggests that small amounts of WDR26 are enough to keep the âWnt offâ state in the canonical Wnt signaling pathway. However, the exression of <italic>Axin2</italic> was increased in the âWnt onâ state (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>E, lane 3 and lane 4). These results suggest that WDR26 contributes to the negative regulation of the canonical Wnt signaling pathway in the âWnt onâ state.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>The specificity of antisense morpholino oligonucleotides for x<styled-content style="fixed-case">WDR</styled-content>26 and si<styled-content style="fixed-case">RNA</styled-content> for <italic>h<styled-content style="fixed-case">WDR</styled-content>26</italic>. (A) Western blotting analysis of injected embryos at stage 10. <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> inhibited the translation of <styled-content style="fixed-case">FLAG</styled-content>âtagged m<styled-content style="fixed-case">RNA</styled-content> containing the targeted site. The translation of <styled-content style="fixed-case">FLAG</styled-content>âtagged m<styled-content style="fixed-case">RNA</styled-content> containing fiveâmismatched sequences at the targeted site was not inhibited by <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content>. Î²âglobin is used as loading control. (B) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis. Three si<styled-content style="fixed-case">RNA</styled-content> against <italic>h<styled-content style="fixed-case">WDR</styled-content>26</italic> were transfected into <styled-content style="fixed-case">HEK</styled-content> 293T cells. <italic><styled-content style="fixed-case">GAPDH</styled-content></italic> was used as a loading control. The value obtained for each <italic>siâh<styled-content style="fixed-case">WDR</styled-content>26</italic>
<styled-content style="fixed-case">RNA</styled-content> was normalized to the level of <italic><styled-content style="fixed-case">GAPDH</styled-content></italic>. The value of transfection of <italic>siâControl</italic>
<styled-content style="fixed-case">RNA</styled-content> (lane 1) was set to 100 and other values were computed. Error bars represent standard deviation of the mean in three experiments. Statistical significances of <italic>h<styled-content style="fixed-case">WDR</styled-content>26</italic>/<italic>h<styled-content style="fixed-case">GAPDH</styled-content></italic> between <italic>siâControl</italic>
<styled-content style="fixed-case">RNA</styled-content> transfection and <italic>siâh<styled-content style="fixed-case">WDR</styled-content>26</italic>
<styled-content style="fixed-case">RNA</styled-content> transfection were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &lt; 0.01 (between lane 1 and each other lane).</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="FEB2-590-1291-g003"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>
<styled-content style="fixed-case">WDR</styled-content>26 is involved in the canonical Wnt pathway. (A) Phenotypes of <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> injected embryos. Controlâ<styled-content style="fixed-case">MO</styled-content> (40 ng) or <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> (40 ng) was coinjected with or without 5âmisâ<italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> plasmids (20 pg) into two dorsal animal blastomeres of eightâcell embryos. Phenotypes are categorized into normal, mild (small eyes), or severe (no eye). The injection of 5âmisâ<italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> plasmids had no effect on head formation. Coinjection of 5âmisâ<italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> plasmids with <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> rescued the phenotypes of the <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>âmorphants. The ratio of each phenotype in the injected embryos was indicated in the graph. Lane 1: <italic>n</italic> = 21, normal (100%). Lane 2: <italic>n</italic> = 45, normal (8.9%), mild (35.5%), severe (55.6%). Lane 3: <italic>n</italic> = 16, normal (81.3%), mild (18.7%). Lane 4: <italic>n</italic> = 14, normal (50.0%), mild (21.4%), severe (28.4%). (BâE) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis. The value obtained for each marker gene or Wnt target gene was normalized to the level of <italic>x<styled-content style="fixed-case">ODC</styled-content></italic> or <italic>h<styled-content style="fixed-case">GAPDH</styled-content></italic>. The value of control (lane 1) was set to 100, and other values were computed (other lanes). Error bars represent standard deviation of the mean in three experiments. Statistical significances of values among indicated lanes were determined by MannâWhitney <italic>U</italic> test. (B) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis of anterior neural marker genes, <italic>x<styled-content style="fixed-case">NCAM</styled-content></italic>,<italic> x<styled-content style="fixed-case">OTX</styled-content>â2</italic>,<italic> x<styled-content style="fixed-case">PAX</styled-content>â6</italic>,<italic> x<styled-content style="fixed-case">SIX</styled-content>â3</italic>,<italic> x<styled-content style="fixed-case">RX</styled-content>â1</italic> in the head region of each molpholinoâ or plasmidâinjected embryo at stage 28. The injection was performed with similar methods indicated in (A). The value of <italic>neural marker gene</italic>/<italic>x<styled-content style="fixed-case">ODC</styled-content></italic> of Controlâ<styled-content style="fixed-case">MO</styled-content> injected embryos (lane 1) was set to 100 and other values were computed. <italic>P</italic> &lt; 0.01: all neural marker genes (between lane 1 and lane 2). <italic>P</italic> &lt; 0.01: neural marker genes except for x<styled-content style="fixed-case">RX</styled-content>â1, <italic>P</italic> &gt; 0.1: x<styled-content style="fixed-case">RX</styled-content>â1 (between lane 1 and lane 3). <italic>P</italic> &lt; 0.01: all neural marker genes (between lane 2 and lane 4). (C) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis of early dorsal Wnt target genes (<italic>Xtwn</italic>,<italic> Siamois</italic>,<italic> Xnr3</italic>) at stage 10. Controlâ<styled-content style="fixed-case">MO</styled-content> (40 ng), <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> (40 ng), and <italic>Xwntâ8</italic> (0.5 pg) m<styled-content style="fixed-case">RNA</styled-content> were ventrally coinjected with <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> m<styled-content style="fixed-case">RNA</styled-content> (500 pg). The value of <italic>Wnt target gene</italic>/<italic>x<styled-content style="fixed-case">ODC</styled-content></italic> of dorsal sectors (lane 1) was set to 100, and other values were computed. The value of uninjected ventral sectors was used as negative control. <italic>P</italic> &lt; 0.005: all Wnt target genes (between lane 2 and lane 3). <italic>P</italic> &lt; 0.005: <italic>Xnr3</italic> and <italic>Siamois</italic>,<italic> P</italic> &gt; 0.1: <italic>Xtwn</italic> (between lane 3 and lane 4). <italic>P</italic> &lt; 0.05: all Wnt target genes (between lane 3 and lane 5). <italic>P</italic> &lt; 0.005: Siamois and Xtwn, <italic>P</italic> &gt; 0.05: Xnr3 (between lane 5 and lane 6). (D) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis of early dorsal Wnt target genes (<italic>Xtwn</italic>,<italic> Siamois</italic>,<italic> Xnr3</italic>). Controlâ<styled-content style="fixed-case">MO</styled-content> (40 ng), <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> (40 ng) and <italic>Xwntâ8</italic> (0.5 pg) m<styled-content style="fixed-case">RNA</styled-content> were ventrally coinjected with <italic>h<styled-content style="fixed-case">WDR</styled-content>26</italic> m<styled-content style="fixed-case">RNA</styled-content> (500 pg). The value of <italic>Wnt target gene</italic>/<italic>x<styled-content style="fixed-case">ODC</styled-content></italic> of ventral sectors (lane1) of Controlâ<styled-content style="fixed-case">MO</styled-content> injected embryos was set to 100, and other values were computed. <italic>P</italic> &lt; 0.005: all Wnt target genes (between lane 1 and lane 2). <italic>P</italic> &lt; 0.005: all Wnt target genes (between lane 1 and lane 3). <italic>P</italic> &lt; 0.005: all Wnt target genes (between lane 2 and lane 4). (E) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis of <italic>hAxin2</italic> in <styled-content style="fixed-case">HEK</styled-content> 293T cells. The <italic>si<styled-content style="fixed-case">RNA</styled-content></italic>âtransfected cultured cells were stimulated with Wnt3A conditioned medium from LâWntâ3A cells for 6 h. The conditioned medium from L cells was used for unstimulated control. The value of <italic>hAxin2</italic>/<italic>h<styled-content style="fixed-case">GAPDH</styled-content></italic> of unstimulated control (lane1) was set to 100, and other values were computed. <italic>P</italic> &gt; 0.1 (between lane 1 and lane 2). <italic>P</italic> &lt; 0.005 (between lane 1 and lane 3). <italic>P</italic> &lt; 0.005 (between lane 3 and lane 4).</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="FEB2-590-1291-g004"/>
        </fig>
      </sec>
      <sec id="feb212180-sec-0012">
        <title>WDR26 affects on the stability of Î²âcatenin</title>
        <p>The homolog of WDR26 in yeast, GID7, is a component of the GID complex that mediates polyubiquitination of proteins <xref rid="feb212180-bib-0016" ref-type="ref">16</xref>. An increase in Î²âcatenin protein in the cytoplasm is essential for canonical Wnt signaling <xref rid="feb212180-bib-0002" ref-type="ref">2</xref>. We investigated whether WDR26 controls the amount of Î²âcatenin protein. The expression of either human or <italic>Xenopus</italic> WDR26 reduced the amount of Î²âcatenin protein in cultured cells in a doseâdependent manner (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>A,B). The reduction of endogenous xÎ²âcatenin protein in the cytoplasmic fraction was observed in <italic>xWDR26 mRNA</italic>âinjected <italic>Xenopus</italic> embryonic cells (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>C). The injection of <italic>hWDR26</italic> mRNA into <italic>Xenopus</italic> embryonic cells also reduced the amount of endogenous xÎ²âcatenin protein in the cytoplasmic fraction (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>D). The knockdown of <italic>hWDR26</italic> by siRNA did not affect on the amount of endogenous hÎ²âcatenin protein in cultured cells (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>E, lane 1 and lane 2). However, the amount of endogenous hÎ²âcatenin protein was increased by the knockdown of <italic>hWDR26</italic> in Wntâstimulated cells (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>E, lane 3 and lane 4). Moreover, in <italic>Xenopus</italic>, the endogenous xÎ²âcatenin protein tended to be upâregulated by the knockdown of xWDR26 (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>F). We also confirmed that both knockdown and overexpression of WDR26 did not affect to the expression of Î²âcatenin mRNA (Fig. S1A, B). Moreover, we investigated Î²âcatenin stability by the cycloheximide chase assay. In results, the transfection of xWDR26 slightly promoted the degradation of Î²âcatenin (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>G). These results suggest that WDR26 controls Î²âcatenin protein stability in the canonical Wnt signaling pathway.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Effects of <styled-content style="fixed-case">WDR</styled-content>26 to the stability of Î²âcatenin. (AâB) Western blotting analysis of ectopically expressed Î²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells. The amounts of transfected plasmids (<italic>h<styled-content style="fixed-case">WDR</styled-content>26</italic> and <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>) were indicated (0, 0.5, 1.5, 5 Î¼g per dish). <styled-content style="fixed-case">GAPDH</styled-content> was used as a loading control. (CâD) Western blotting analysis of endogenous xÎ²âcatenin in <italic>Xenopus</italic> embryonic cells. The amounts of injected m<styled-content style="fixed-case">RNA</styled-content> (<italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> and <italic>h<styled-content style="fixed-case">WDR</styled-content>26</italic>) were indicated (0, 250, 1000 pg per embryo). Cytoplasmic fractions of lysates extracted at the gastrula stage were used here. (E) Western blotting analysis of endogenous hÎ²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells. <italic>siâh<styled-content style="fixed-case">WDR</styled-content>26â3</italic>, an si<styled-content style="fixed-case">RNA</styled-content> against <italic>h<styled-content style="fixed-case">WDR</styled-content>26,</italic> was transfected into <styled-content style="fixed-case">HEK</styled-content> 293T cells. Twentyâfour hours after transfection, cells were stimulated with Wnt3A for 6 h. Relative intensity of each western blot (upper panel) was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of hÎ²âcatenin/h<styled-content style="fixed-case">GAPDH</styled-content> were calculated and graphed. The value obtained for each hÎ²âcatenin signal was normalized to the level of h<styled-content style="fixed-case">GAPDH</styled-content> signal. The value of unstimulated control (lane 1) was set to 100, and other values were computed (other lanes). Error bars represent standard deviation of the mean in three experiments. Statistical significances of values among indicated lanes were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &gt; 0.1 (between lane 1 and lane 2). <italic>P</italic> &lt; 0.005 (between lane 1 and lane 3). <italic>P</italic> &lt; 0.005 (between lane 3 and lane 4). (F) Western blotting analysis of endogenous xÎ²âcatenin in <italic>Xenopus</italic> embryonic cells. <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic>â<styled-content style="fixed-case">MO</styled-content> (40 ng) was injected into animal blastomeres of eightâcell embryos, and lysates were extracted at the gastrula stage. <italic>x</italic>Î²<italic>âcatenin</italic>â<styled-content style="fixed-case">MO</styled-content> was used as a positive control. Relative intensity of each western blot (upper panel) was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of xÎ²âcatenin/x<styled-content style="fixed-case">GAPDH</styled-content> were calculated and graphed (bottom panel). The value for Controlâ<styled-content style="fixed-case">MO</styled-content>âinjected embryos (lane 1) was set to 100, and other values were computed (other lanes). Error bars represent standard deviation of the mean in three experiments. Statistical significances of values among indicated lanes were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &lt; 0.01 (between lane 1 and lane 2). <italic>P</italic> &lt; 0.01 (between lane 1 and lane 3). (G) Western blotting analysis of the stability of Î²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells. x<styled-content style="fixed-case">WDR</styled-content>26 was transfected at 24 h after transfection of xÎ²âcatenin. Five hours after the transfection x<styled-content style="fixed-case">WDR</styled-content>26, cells were stimulated with cycloheximide (<styled-content style="fixed-case">CHX</styled-content>) (20 mgÂ·mL<sup>â1</sup>) during indicated hours. We measured relative intensity of each western blot (upper panel) by <sc>imagej</sc>, calculated the ratios of Î²âcatenin/<styled-content style="fixed-case">GAPDH</styled-content>, and graphed (bottom panel). The value for cells untreated with cyclohexmide was set to 100, and other values were computed (other lanes). Solid line indicates ratios of Î²âcatenin/<styled-content style="fixed-case">GAPDH</styled-content> (left panels) as control. Dotted line indicates ratios of Î²âcatenin/<styled-content style="fixed-case">GAPDH</styled-content> with x<styled-content style="fixed-case">WDR</styled-content>26 transfection (right panels).</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="FEB2-590-1291-g005"/>
        </fig>
      </sec>
      <sec id="feb212180-sec-0013">
        <title>Possible mechanisms of Î²âcatenin degradation by WDR26</title>
        <p>We found that hWDR26 did not bind to hÎ²âcatenin (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>A) although hAxin1 binds to both hWDR26 and hÎ²âcatenin (Figs <xref rid="feb212180-fig-0001" ref-type="fig">1</xref> and <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>A and ref. <xref rid="feb212180-bib-0006" ref-type="ref">6</xref>). This suggests that WDR26 controls the stability of Î²âcatenin through binding with Axin1. To examine the binding site of WDR26 with Axin1 in detail, we made deletion constructs of xWDR26, removing either the LisH domain, the CTLH domain, or both domains (see Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>B, upper). The CTLH domainâdeleted construct bound to xAxin1, but the LisH domainâdeleted and the LisHâCTLH domainâdeleted constructs did not bind (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>B). The expression of Wnt target genes induced by ventral injection with <italic>Xwntâ8</italic> mRNA was decreased by coinjection with <italic>xWDR26</italic> mRNA, but not by mRNA of the LisH domainâdeleted construct (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>C). Moreover, the expression of the LisH domainâdeleted WDR26 construct hardly reduces the amount of xÎ²âcatenin protein (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>D), suggesting that binding between WDR26 and Axin is necessary for Î²âcatenin degradation. To confirm that WDR26 contributes to the ubiquitination of Î²âcatenin, we investigated whether the ubiquitination of Î²âcatenin is altered in the presence of the proteasome inhibitor, MGâ132. First, we confirmed the ubiquitination of xÎ²âcatenin without the MGâ132 treatment. Although the ubiquitination of xÎ²âcatenin was not increased by transfection of xWDR26 or xAxin1, both transfection of xWDR26 and xAxin1 slightly increased the ubiquitination of xÎ²âcatenin (Figs <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>E and S2, lane 1 to lane 4). This suggests that the ubiquitinated xÎ²âcatenin could be immediately degraded via the ubiquitin proteasome pathway in the âWnt offâ state. Under the MGâ132 treatments, the ubiquitination of xÎ²âcatenin was only slightly increased by cotransfection of xAxin1 alone, but the cotransfection of both xWDR26 and xAxin1 highly increased the ubiquitination of xÎ²âcatenin (Figs <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>F and S2, lane 5 to lane 8). We considered that the amount of Î²âcatenin was reduced during 24 h before the treatments with MGâ132 (see figure legends). These results suggest that WDR26 regulates the ubiquitination of Î²âcatenin for its degradation, and that binding of WDR26 and Axin is important for this ubiquitination.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Interaction between <styled-content style="fixed-case">WDR</styled-content>26 and Axon1 is critical for Î²âcatenin degradation. (A) Interaction between ectopically expressed h<styled-content style="fixed-case">WDR</styled-content>26 and hÎ²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells. As a positive control, the binding between hAxin1 and hÎ²âcatenin was observed. (B) Interactions among ectopically expressed xAxin1 and truncated x<styled-content style="fixed-case">WDR</styled-content>26 constructs. A schematic of x<styled-content style="fixed-case">WDR</styled-content>26 and truncated constructs is indicated in the upper side. Asterisks indicate original size of each construct, and several bands of high molecular weight were observed. (C) Quantitative <styled-content style="fixed-case">RT</styled-content>â<styled-content style="fixed-case">PCR</styled-content> analysis of early dorsal Wnt target genes (<italic>Xtwn</italic>,<italic> Siamois</italic>,<italic> Xnr3</italic>). <italic>x<styled-content style="fixed-case">WDR</styled-content>26</italic> or <italic>x<styled-content style="fixed-case">WDR</styled-content>26âdeltaLisH</italic> m<styled-content style="fixed-case">RNA</styled-content> (500 pg) and <italic>Xwntâ8</italic> (0.5 pg) m<styled-content style="fixed-case">RNA</styled-content> were ventrally coinjected. The value obtained for each Wnt target gene was normalized to the level of <italic>x<styled-content style="fixed-case">ODC</styled-content></italic>. The value of <italic>Wnt target gene</italic>/<italic>x<styled-content style="fixed-case">ODC</styled-content></italic> of only <italic>Xwntâ8</italic>âinjected embryos (lane 1) was set to 100, and other values were computed. Statistical significances of values among indicated lanes were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &lt; 0.01: all Wnt target genes (between lane 1 and lane 2). <italic>P</italic> &gt; 0.1: all Wnt target genes (between lane 1 and lane 3). <italic>P</italic> &lt; 0.01: all Wnt target genes (between lane 2 and lane 3). (D) Western blotting analysis of ectopically expressed Î²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells. The amounts of transfected plasmid, <italic>x<styled-content style="fixed-case">WDR</styled-content>26âdeltaLisH,</italic> were gradually increased (0, 0.5, 1.5, 5 Î¼g per dish). (E and F) Western blotting analysis of ubiquitinated xÎ²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells. At 24 h after transfection, cells were untreated (E) or treated with 10 Î¼<sc>m</sc>
<styled-content style="fixed-case">MG</styled-content>â132 for 24 h (F). The <styled-content style="fixed-case">HA</styled-content>âUbiquitin was cotransfected to detect ubiquitinated xÎ²âcatenin.</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="FEB2-590-1291-g006"/>
        </fig>
        <p>GSKâ3Î² plays a key role in the Î²âcatenin degradation, and xWDR26 bound to xAxin1 at the central region including GSK3Î²âbinding domain (Fig. <xref rid="feb212180-fig-0001" ref-type="fig">1</xref>E). Therefore, we investigated whether GSKâ3Î² affects on the function of WDR26 and the binding between WDR26 and Axin. The lithium chloride and SB216763 are GSKâ3Î² inhibitors, and increased the stability of Î²âcatenin (Fig. <xref rid="feb212180-fig-0007" ref-type="fig">7</xref>A, B, lane 1 and lane 3). However xWDR26 reduced the stability of Î²âcatenin under these treatments (Fig. <xref rid="feb212180-fig-0007" ref-type="fig">7</xref>A,B, lane 3 and lane 4). This suggests that the function of xGSKâ3Î² would be not related with the WDR26 function for the Î²âcatenin stability. Also, xGSKâ3Î² did not increase and decrease the association between xWDR26 and xAxin1 (Fig. <xref rid="feb212180-fig-0007" ref-type="fig">7</xref>C). These suggest that the mechanisms of degradation of Î²âcatenin by WDR26 would be independent from the canonical degradation mechanisms by the APC/Axin/GSKâ3Î² complex.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212180-fig-0007" orientation="portrait" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Effects of <styled-content style="fixed-case">GSK</styled-content>â3Î² on <styled-content style="fixed-case">WDR</styled-content>26 function. (A and B) Western blotting analysis of ectopically expressed Î²âcatenin in <styled-content style="fixed-case">HEK</styled-content> 293T cells with or without lithium chloride treatments (A) and <styled-content style="fixed-case">SB</styled-content>216763 treatments (B). <styled-content style="fixed-case">GAPDH</styled-content> was used as a loading control. (C) Interaction between ectopically expressed x<styled-content style="fixed-case">WDR</styled-content>26 and xAxin1 in <styled-content style="fixed-case">HEK</styled-content> 293T cells with or without cotransfection of <styled-content style="fixed-case">GSK</styled-content>â3Î². The amounts of transfected plasmids (<italic><styled-content style="fixed-case">GSK</styled-content>â3</italic>Î²) were indicated (0, 0.5, 1.5, 5 Î¼g per dish). <styled-content style="fixed-case">GAPDH</styled-content> was used as a loading control. Relative intensity of each western blot was measured by <sc>imagej</sc>. The ratios of <styled-content style="fixed-case">IP</styled-content>/Input of x<styled-content style="fixed-case">WDR</styled-content>26 were calculated. Their statistical significances were determined by MannâWhitney <italic>U</italic> test. <italic>P</italic> &gt; 0.1 (between lane 7/lane 2 and lane 8/lane 3). <italic>P</italic> &gt; 0.1 (between lane 7/lane 2 and lane 9/lane 4). <italic>P</italic> &gt; 0.1 (between lane 7/lane 2 and lane 10/lane 5).</p>
          </caption>
          <graphic id="nlm-graphic-15" xlink:href="FEB2-590-1291-g007"/>
        </fig>
      </sec>
    </sec>
    <sec id="feb212180-sec-0014">
      <title>Discussion</title>
      <p>In this study, we showed WDR26 is important for degradation of Î²âcatenin in the canonical Wnt signaling pathway. In <italic>Xenopus</italic> development, the inactivation of the Wnt signal by antagonists such as DKKâ1 and Cerberus is necessary for head formation <xref rid="feb212180-bib-0028" ref-type="ref">28</xref>, <xref rid="feb212180-bib-0030" ref-type="ref">30</xref>. Expression of <italic>xWDR26</italic> is strongly localized to the anterior neural region after the neurula stage (Fig. <xref rid="feb212180-fig-0002" ref-type="fig">2</xref>D,E). Additionally, knockdown of xWDR26 in the anterior ectodermal region inhibited head formation, including eyes and marker genes (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>A,B). Moreover, Wnt target genes were increased by the knockdown of xWDR26 (Fig. <xref rid="feb212180-fig-0004" ref-type="fig">4</xref>D). These suggest that WDR26 acts as a negative regulator of Wnt signaling during embryogenesis.</p>
      <p>The degradation of Î²âcatenin is regulated by the complex of Axin, APC, and GSKâ3Î² in the âWnt offâ state. The amount of Î²âcatenin protein was reduced by the expression of WDR26 (Fig. <xref rid="feb212180-fig-0005" ref-type="fig">5</xref>A,B), although we did not confirm direct binding of WDR26 to Î²âcatenin (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>A). Interestingly, the deleted construct of xWDR26 that did not bind to xAxin1, did not reduce significantly either the expression of Wnt target genes or Î²âcatenin levels (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>C,D). Moreover, the coexpression of Axin1 and WDR26 increased the ubiquitination of Î²âcatenin (Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>E). These results suggest that the degradation of Î²âcatenin by WDR26 requires binding between WDR26 and Axin1, and WDR26 is a component of the Î²âcatenin degradation complex. Axin1 was also expressed in the anterior neural region in <italic>Xenopus</italic> embryos (data not shown and ref. <xref rid="feb212180-bib-0031" ref-type="ref">31</xref>), suggesting that WDR26 and Axin1 regulate anterior formation through their inhibitory effects in <italic>Xenopus</italic> development. A recent report indicated that oxidative stress induces apoptosis and regulates the expression of WDR26 in cardiomyocytes. Moreover, the expression of WDR26 inhibits apoptosis induced by oxidative stress <xref rid="feb212180-bib-0032" ref-type="ref">32</xref>. However, overexpression and activation of Î²âcatenin induces apoptosis during carcinogenesis and development <xref rid="feb212180-bib-0033" ref-type="ref">33</xref>, <xref rid="feb212180-bib-0034" ref-type="ref">34</xref>, <xref rid="feb212180-bib-0035" ref-type="ref">35</xref>. In melanoma cells, Axin1 acts as a mediator of apoptosis with Î²âcatenin activation and BRAF inhibition <xref rid="feb212180-bib-0036" ref-type="ref">36</xref>. Taken together, these facts suggest that WDR26 and Axin1 play coordinating roles for the inhibitory effects through the degradation of Î²âcatenin in Wnt signaling pathway.</p>
      <p>Vertebrate Î²âcatenin has 26 lysine residues, and each lysine position is well conserved. Recent studies indicated the presence of several ubiquitination pathways of Î²âcatenin. Î²âTrCP ubiquitinates on lysine 19 and 49 of Î²âcatenin in a phosphorylationâdependent manner, while Siahâ1 ubiquitinates Î²âcatenin on lysine 660 and 671 in the p53âdependent pathway <xref rid="feb212180-bib-0037" ref-type="ref">37</xref>, <xref rid="feb212180-bib-0038" ref-type="ref">38</xref>. Jadeâ1 ubiquitinates Î²âcatenin in a similar phosphorylationâdependent manner to Î²âTrCP, but the ubiquitination by Jadeâ1 occurs in both âWnt offâ and âWnt onâ states <xref rid="feb212180-bib-0038" ref-type="ref">38</xref>, <xref rid="feb212180-bib-0039" ref-type="ref">39</xref>. However, it is known that ARMc8/GID5 and RMND5/GID2, predicted vertebrate homologs of the GID complex, contribute to the ubiquitination pathway. ARMc8 binds to Î±âcatenin to target it for degradation by the proteasome <xref rid="feb212180-bib-0018" ref-type="ref">18</xref>, and RMND5 has an E3 ubiquitinâligase activity and inhibits forebrain formation in <italic>Xenopus</italic>, like WDR26 <xref rid="feb212180-bib-0019" ref-type="ref">19</xref>. Therefore, it is suggested that WDR26 forms a new ubiquitination pathway of Î²âcatenin with vertebrate GID complex homologs. Further study will be needed to identify how WDR26 controls the ubiquitination of Î²âcatenin.</p>
    </sec>
    <sec id="feb212180-sec-0016">
      <title>Author contributions</title>
      <p>HS and TN conceived and supervised the study; TG, JM, and SI performed experiments; TG and HS wrote the manuscript.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Fig. S1.</bold> (A) Quantitative RTâPCR analysis of <italic>h</italic>Î²<italic>âcatenin</italic> in HEK 293T cells. (B) Quantitative RTâPCR analysis of <italic>x</italic>Î²<italic>âcatenin</italic> in <italic>Xenopus</italic> embryonic cells.</p>
        </caption>
        <media xlink:href="FEB2-590-1291-s001.tiff">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Fig. S2.</bold> Semiquantitative analysis of western blots in Fig. <xref rid="feb212180-fig-0006" ref-type="fig">6</xref>E,F.</p>
        </caption>
        <media xlink:href="FEB2-590-1291-s002.tiff">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="feb212180-sec-0015">
      <title>Acknowledgements</title>
      <p>This work was supported by GrantsâinâAid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.</p>
    </ack>
    <ref-list content-type="cited-references" id="feb212180-bibl-0001">
      <title>References</title>
      <ref id="feb212180-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0001">
<string-name>
<surname>Logan</surname>
<given-names>CY</given-names>
</string-name> and <string-name>
<surname>Nusse</surname>
<given-names>R</given-names>
</string-name> (<year>2004</year>) <article-title>The Wnt signaling pathway in development and disease</article-title>. <source>Annu Rev Cell Dev Biol</source>
<volume>20</volume>, <fpage>781</fpage>â<lpage>810</lpage>.<pub-id pub-id-type="pmid">15473860</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0002">
<string-name>
<surname>Clevers</surname>
<given-names>H</given-names>
</string-name> (<year>2006</year>) <article-title>Wnt/betaâcatenin signaling in development and disease</article-title>. <source>Cell</source>
<volume>127</volume>, <fpage>469</fpage>â<lpage>480</lpage>.<pub-id pub-id-type="pmid">17081971</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0003">
<string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Semenov</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baeg</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name> and <string-name>
<surname>He</surname>
<given-names>X</given-names>
</string-name> (<year>2002</year>) <article-title>Control of betaâcatenin phosphorylation/degradation by a dualâkinase mechanism</article-title>. <source>Cell</source>
<volume>108</volume>, <fpage>837</fpage>â<lpage>847</lpage>.<pub-id pub-id-type="pmid">11955436</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0004">
<string-name>
<surname>Winer</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Bommer</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Gonik</surname>
<given-names>N</given-names>
</string-name> and <string-name>
<surname>Fearon</surname>
<given-names>ER</given-names>
</string-name> (<year>2006</year>) <article-title>Lysine residues Lysâ19 and Lysâ49 of betaâcatenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation</article-title>. <source>J Biol Chem</source>
<volume>281</volume>, <fpage>26181</fpage>â<lpage>26187</lpage>.<pub-id pub-id-type="pmid">16849322</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0005">
<string-name>
<surname>Bienz</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Clevers</surname>
<given-names>H</given-names>
</string-name> (<year>2000</year>) <article-title>Linking colorectal cancer to Wnt signaling</article-title>. <source>Cell</source>
<volume>103</volume>, <fpage>311</fpage>â<lpage>320</lpage>.<pub-id pub-id-type="pmid">11057903</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0006">
<string-name>
<surname>Ikeda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kishida</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Murai</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Kikuchi</surname>
<given-names>A</given-names>
</string-name> (<year>1998</year>) <article-title>Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSKâ3beta and betaâcatenin and promotes GSKâ3betaâdependent phosphorylation of betaâcatenin</article-title>. <source>EMBO J</source>
<volume>17</volume>, <fpage>1371</fpage>â<lpage>1384</lpage>.<pub-id pub-id-type="pmid">9482734</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0007">
<string-name>
<surname>Kishida</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kishida</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sakamoto</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Kikuchi</surname>
<given-names>A</given-names>
</string-name> (<year>1998</year>) <article-title>Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of betaâcatenin</article-title>. <source>J Biol Chem</source>
<volume>273</volume>, <fpage>10823</fpage>â<lpage>10826</lpage>.<pub-id pub-id-type="pmid">9556553</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0008">
<string-name>
<surname>Hart</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>de los Santos</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Albert</surname>
<given-names>IN</given-names>
</string-name>, <string-name>
<surname>Rubinfeld</surname>
<given-names>B</given-names>
</string-name>and <string-name>
<surname>Polakis</surname>
<given-names>P</given-names>
</string-name> (<year>1998</year>) <article-title>Downregulation of betaâcatenin by human Axin and its association with the APC tumor suppressor, betaâcatenin and GSK3 beta</article-title>. <source>Curr Biol</source>
<volume>8</volume>, <fpage>573</fpage>â<lpage>581</lpage>.<pub-id pub-id-type="pmid">9601641</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0009">
<string-name>
<surname>Satoh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Daigo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Furukawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Miwa</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nishiwaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kawasoe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishiguro</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fujita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tokino</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic> (<year>2000</year>) <article-title>AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virusâmediated transfer of AXIN1</article-title>. <source>Nat Genet</source>
<volume>24</volume>, <fpage>245</fpage>â<lpage>250</lpage>.<pub-id pub-id-type="pmid">10700176</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0010">
<string-name>
<surname>Itoh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Krupnik</surname>
<given-names>VE</given-names>
</string-name> and <string-name>
<surname>Sokol</surname>
<given-names>SY</given-names>
</string-name> (<year>1998</year>) <article-title>Axis determination in <italic>Xenopus</italic> involves biochemical interactions of axin, glycogen synthase kinase 3 and betaâcatenin</article-title>. <source>Curr Biol</source>
<volume>8</volume>, <fpage>591</fpage>â<lpage>594</lpage>.<pub-id pub-id-type="pmid">9601644</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0011">
<string-name>
<surname>Rui</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Z</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>A betaâcateninâindependent dorsalization pathway activated by Axin/JNK signaling and antagonized by aida</article-title>. <source>Dev Cell</source>
<volume>13</volume>, <fpage>268</fpage>â<lpage>282</lpage>.<pub-id pub-id-type="pmid">17681137</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0012">
<string-name>
<surname>Francis</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Adams</surname>
<given-names>JC</given-names>
</string-name> (<year>2013</year>) <article-title>Molecular phylogeny of a RING E3 ubiquitin ligase, conserved in eukaryotic cells and dominated by homologous components, the muskelin/RanBPM/CTLH complex</article-title>. <source>PLoS One</source>
<volume>8</volume>, <fpage>e75217</fpage>.<pub-id pub-id-type="pmid">24143168</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0013">
<string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>
<italic>et al</italic> (<year>2004</year>) <article-title>WDR26: a novel Gbetaâlike protein, suppresses MAPK signaling pathway</article-title>. <source>J Cell Biochem</source>
<volume>93</volume>, <fpage>579</fpage>â<lpage>587</lpage>.<pub-id pub-id-type="pmid">15378603</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0014">
<string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name> (<year>2011</year>) <article-title>The WD40 repeat protein WDR26 binds GÎ²Î³ and promotes GÎ²Î³âdependent signal transduction and leukocyte migration</article-title>. <source>J Biol Chem</source>
<volume>286</volume>, <fpage>43902</fpage>â<lpage>43912</lpage>.<pub-id pub-id-type="pmid">22065575</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0015">
<string-name>
<surname>Runne</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name> (<year>2013</year>) <article-title>WD40ârepeat proteins control the flow of GÎ²Î³ signaling for directional cell migration</article-title>. <source>Cell Adh Migr</source>
<volume>7</volume>, <fpage>214</fpage>â<lpage>218</lpage>.<pub-id pub-id-type="pmid">23302952</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0016">
<string-name>
<surname>Santt</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Pfirrmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Braun</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Juretschke</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kimmig</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Scheel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hofmann</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Thumm</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Wolf</surname>
<given-names>DH</given-names>
</string-name> (<year>2008</year>) <article-title>The yeast GID complex, a novel ubiquitin ligase (E3) involved in the regulation of carbohydrate metabolism</article-title>. <source>Mol Biol Cell</source>
<volume>19</volume>, <fpage>3323</fpage>â<lpage>3333</lpage>.<pub-id pub-id-type="pmid">18508925</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0017">
<string-name>
<surname>Menssen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Schweiggert</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schreiner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kusevic</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Reuther</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Braun</surname>
<given-names>B</given-names>
</string-name> and <string-name>
<surname>Wolf</surname>
<given-names>DH</given-names>
</string-name> (<year>2012</year>) <article-title>Exploring the topology of the Gid complex, the E3 ubiquitin ligase involved in cataboliteâinduced degradation of gluconeogenic enzymes</article-title>. <source>J Biol Chem</source>
<volume>287</volume>, <fpage>25602</fpage>â<lpage>25614</lpage>.<pub-id pub-id-type="pmid">22645139</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0018">
<string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ueda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tomaru</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takeno</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Ishigatsubo</surname>
<given-names>Y</given-names>
</string-name> (<year>2008</year>) <article-title>Proteasomeâdependent degradation of alphaâcatenin is regulated by interaction with ARMc8alpha</article-title>. <source>Biochem J</source>
<volume>411</volume>, <fpage>581</fpage>â<lpage>591</lpage>.<pub-id pub-id-type="pmid">18215130</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0019">
        <label>19</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0019">
<string-name>
<surname>Pfirrmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>VillavicencioâLorini</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Subudhi</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Menssen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>DH</given-names>
</string-name> and <string-name>
<surname>Hollemann</surname>
<given-names>T</given-names>
</string-name> (<year>2015</year>) <article-title>RMND5 from <italic>Xenopus laevis</italic> is an E3 ubiquitinâligase and functions in early embryonic forebrain development</article-title>. <source>PLoS One</source>
<volume>10</volume>, <fpage>e0120342</fpage>.<pub-id pub-id-type="pmid">25793641</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0020">
        <label>20</label>
        <mixed-citation publication-type="book" id="feb212180-cit-0020">
<string-name>
<surname>Iemura</surname>
<given-names>SI</given-names>
</string-name> and <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name> (<year>2012</year>) <chapter-title>(2012) Oneâbyâone sample preparation method for protein network analysis</chapter-title> In <source>Protein Interaction</source> (<person-group person-group-type="editor"><name><surname>Cai</surname><given-names>J</given-names></name></person-group>, ed), pp. <fpage>293</fpage>â<lpage>310</lpage>. <publisher-name>Intech</publisher-name>, <publisher-loc>Rijeka, Croatia</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="feb212180-bib-0021">
        <label>21</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0021">
<string-name>
<surname>Goto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fukui</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shibuya</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Keller</surname>
<given-names>R</given-names>
</string-name> and <string-name>
<surname>Asashima</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>) <article-title>
<italic>Xenopus</italic> furry contributes to release of microRNA gene silencing</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>107</volume>, <fpage>19344</fpage>â<lpage>19349</lpage>.<pub-id pub-id-type="pmid">20974966</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0022">
        <label>22</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0022">
<string-name>
<surname>Goto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Adachi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Iemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Shibuya</surname>
<given-names>H</given-names>
</string-name> (<year>2013</year>) <article-title>IQGAP1 protein regulates nuclear localization of Î²âcatenin via importinâÎ²5 protein in Wnt signaling</article-title>. <source>J Biol Chem</source>
<volume>288</volume>, <fpage>36351</fpage>â<lpage>36360</lpage>.<pub-id pub-id-type="pmid">24196961</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0023">
        <label>23</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0023">
<string-name>
<surname>Shimizu</surname>
<given-names>K</given-names>
</string-name> and <string-name>
<surname>Gurdon</surname>
<given-names>JB</given-names>
</string-name> (<year>1999</year>) <article-title>A quantitative analysis of signal transduction from activin receptor to nucleus and its relevance to morphogen gradient interpretation</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>96</volume>, <fpage>6791</fpage>â<lpage>6796</lpage>.<pub-id pub-id-type="pmid">10359791</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0024">
        <label>24</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0024">
<string-name>
<surname>Satoh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ohnishi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Takeyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Shibuya</surname>
<given-names>H</given-names>
</string-name> (<year>2007</year>) <article-title>Nemoâlike kinaseâmyocyte enhancer factor 2A signaling regulates anterior formation in <italic>Xenopus</italic> development</article-title>. <source>Mol Cell Biol</source>
<volume>27</volume>, <fpage>7623</fpage>â<lpage>7630</lpage>.<pub-id pub-id-type="pmid">17785444</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0025">
        <label>25</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0025">
<string-name>
<surname>Goto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Adachi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Satoh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Shibuya</surname>
<given-names>H</given-names>
</string-name> (<year>2013</year>) <article-title>IQGAP1 functions as a modulator of dishevelled nuclear localization in Wnt signaling</article-title>. <source>PLoS One</source>
<volume>8</volume>, <fpage>e60865</fpage>.<pub-id pub-id-type="pmid">23577172</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0026">
        <label>26</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0026">
<string-name>
<surname>Shimizu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Shibuya</surname>
<given-names>H</given-names>
</string-name> (<year>2013</year>) <article-title>WNK4 is an essential effector of anterior formation in FGF signaling</article-title>. <source>Genes Cells</source>
<volume>18</volume>, <fpage>442</fpage>â<lpage>449</lpage>.<pub-id pub-id-type="pmid">23517227</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0027">
        <label>27</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0027">
<string-name>
<surname>Harland</surname>
<given-names>RM</given-names>
</string-name> (<year>1991</year>) <article-title>
<italic>In situ</italic> hybridization: an improved wholeâmount method for <italic>Xenopus</italic> embryos</article-title>. <source>Methods Cell Biol</source>
<volume>36</volume>, <fpage>685</fpage>â<lpage>695</lpage>.<pub-id pub-id-type="pmid">1811161</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0028">
        <label>28</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0028">
<string-name>
<surname>Glinka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Onichtchouk</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Blumenstock</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Niehrs</surname>
<given-names>C</given-names>
</string-name> (<year>1997</year>) <article-title>Head induction by simultaneous repression of Bmp and Wnt signalling in <italic>Xenopus</italic>
</article-title>. <source>Nature</source>
<volume>389</volume>, <fpage>517</fpage>â<lpage>519</lpage>.<pub-id pub-id-type="pmid">9333244</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0029">
        <label>29</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0029">
<string-name>
<surname>Shibata</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ono</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hikasa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shinga</surname>
<given-names>J</given-names>
</string-name> and <string-name>
<surname>Taira</surname>
<given-names>M</given-names>
</string-name> (<year>2000</year>) <article-title>
<italic>Xenopus</italic> crescent encoding a Frizzledâlike domain is expressed in the Spemann organizer and pronephros</article-title>. <source>Mech Dev</source>
<volume>96</volume>, <fpage>243</fpage>â<lpage>246</lpage>.<pub-id pub-id-type="pmid">10960792</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0030">
        <label>30</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0030">
<string-name>
<surname>SemÃ«nov</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Tamai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brott</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>KÃ¼hl</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sokol</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>He</surname>
<given-names>X</given-names>
</string-name> (<year>2001</year>) <article-title>Head inducer Dickkopfâ1 is a ligand for Wnt coreceptor LRP6</article-title>. <source>Curr Biol</source>
<volume>11</volume>, <fpage>951</fpage>â<lpage>961</lpage>.<pub-id pub-id-type="pmid">11448771</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0031">
        <label>31</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0031">
<string-name>
<surname>Hedgepeth</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Deardorff</surname>
<given-names>MA</given-names>
</string-name> and <string-name>
<surname>Klein</surname>
<given-names>PS</given-names>
</string-name> (<year>1999</year>) <article-title>
<italic>Xenopus</italic> axin interacts with glycogen synthase kinaseâ3 beta and is expressed in the anterior midbrain</article-title>. <source>Mech Dev</source>
<volume>80</volume>, <fpage>147</fpage>â<lpage>151</lpage>.<pub-id pub-id-type="pmid">10072781</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0032">
        <label>32</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0032">
<string-name>
<surname>Feng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Xiao</surname>
<given-names>X</given-names>
</string-name> (<year>2012</year>) <article-title>A novel WDârepeat protein, WDR26, inhibits apoptosis of cardiomyocytes induced by oxidative stress</article-title>. <source>Free Radic Res</source>
<volume>46</volume>, <fpage>777</fpage>â<lpage>784</lpage>.<pub-id pub-id-type="pmid">22448652</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0033">
        <label>33</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0033">
<string-name>
<surname>Ahmed</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Wieschaus</surname>
<given-names>E</given-names>
</string-name> (<year>1998</year>) <article-title>Regulation of armadillo by a <italic>Drosophila</italic> APC inhibits neuronal apoptosis during retinal development</article-title>. <source>Cell</source>
<volume>93</volume>, <fpage>1171</fpage>â<lpage>1182</lpage>.<pub-id pub-id-type="pmid">9657150</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0034">
        <label>34</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0034">
<string-name>
<surname>Wong</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Rubinfeld</surname>
<given-names>B</given-names>
</string-name> and <string-name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</string-name> (<year>1998</year>) <article-title>Effects of forced expression of an NH2âterminal truncated betaâCatenin on mouse intestinal epithelial homeostasis</article-title>. <source>J Cell Biol</source>
<volume>141</volume>, <fpage>765</fpage>â<lpage>777</lpage>.<pub-id pub-id-type="pmid">9566975</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0035">
        <label>35</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0035">
<string-name>
<surname>Damalas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>BenâZe'ev</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Simcha</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Shtutman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Leal</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Zhurinsky</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Geiger</surname>
<given-names>B</given-names>
</string-name> and <string-name>
<surname>Oren</surname>
<given-names>M</given-names>
</string-name> (<year>1999</year>) <article-title>Excess betaâcatenin promotes accumulation of transcriptionally active p53</article-title>. <source>EMBO J</source>
<volume>18</volume>, <fpage>3054</fpage>â<lpage>3063</lpage>.<pub-id pub-id-type="pmid">10357817</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0036">
        <label>36</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0036">
<string-name>
<surname>Biechele</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Kulikauskas</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Toroni</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Lucero</surname>
<given-names>OM</given-names>
</string-name>, <string-name>
<surname>Swift</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Robin</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Moon</surname>
<given-names>RT</given-names>
</string-name> and <string-name>
<surname>Chien</surname>
<given-names>AJ</given-names>
</string-name> (<year>2012</year>) <article-title>Wnt/Î²âcatenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma</article-title>. <source>Sci Signal</source>
<volume>5</volume>, <fpage>ra3</fpage>.<pub-id pub-id-type="pmid">22234612</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0037">
        <label>37</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0037">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rote</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Yost</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Neufeld</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>RL</given-names>
</string-name> and <string-name>
<surname>Matsunami</surname>
<given-names>N</given-names>
</string-name> (<year>2001</year>) <article-title>Siahâ1 mediates a novel betaâcatenin degradation pathway linking p53 to the adenomatous polyposis coli protein</article-title>. <source>Mol Cell</source>
<volume>7</volume>, <fpage>927</fpage>â<lpage>936</lpage>.<pub-id pub-id-type="pmid">11389840</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0038">
        <label>38</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0038">
<string-name>
<surname>Tauriello</surname>
<given-names>DV</given-names>
</string-name> and <string-name>
<surname>Maurice</surname>
<given-names>MM</given-names>
</string-name> (<year>2010</year>) <article-title>The various roles of ubiquitin in Wnt pathway regulation</article-title>. <source>Cell Cycle</source>
<volume>9</volume>, <fpage>3700</fpage>â<lpage>3709</lpage>.<pub-id pub-id-type="pmid">20930545</pub-id></mixed-citation>
      </ref>
      <ref id="feb212180-bib-0039">
        <label>39</label>
        <mixed-citation publication-type="journal" id="feb212180-cit-0039">
<string-name>
<surname>Chitalia</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Foy</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Bachschmid</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Panchenko</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Bharti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Seldin</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Lecker</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Dominguez</surname>
<given-names>I</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Jadeâ1 inhibits Wnt signalling by ubiquitylating betaâcatenin and mediates Wnt pathway inhibition by pVHL</article-title>. <source>Nat Cell Biol</source>
<volume>10</volume>, <fpage>1208</fpage>â<lpage>1216</lpage>.<pub-id pub-id-type="pmid">18806787</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>